Treatment of acute demyelinating optic neuritis. - Wikidata - awgldk - TriplyDB

Treatment of acute demyelinating optic neuritis.

Treatment of acute demyelinating optic neuritis.

http://www.wikidata.org/entity/Q30974206

about

The role of magnetic resonance imaging and visual evoked potential in management of optic neuritis Visual recovery from optic atrophy following acute optic neuropathy in the fellow eye.

P2860

Q33860213-30D64ECE-721A-4836-A96F-158622CACD4C Q40038473-4B05BC9F-032E-4DE4-88F0-E15F3B85F193

P2860

Treatment of acute demyelinating optic neuritis.

http://www.wikidata.org/entity/Q30974206

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Treatment of acute demyelinating optic neuritis.

@ast

Treatment of acute demyelinating optic neuritis.

@en

type

label

Treatment of acute demyelinating optic neuritis.

@ast

Treatment of acute demyelinating optic neuritis.

@en

prefLabel

Treatment of acute demyelinating optic neuritis.

@ast

Treatment of acute demyelinating optic neuritis.

@en

P1433

Q30974206-3A599481-BACC-40E2-9BCF-3AF2A3304D33

P1476

Q30974206-275FC985-DB59-42A5-93D1-CA92DCBA79E7

P2860

Q30974206-088A3241-04EE-4846-B9B4-84A702594B0E

Q30974206-0B964014-AFA2-418A-A463-DB0605462F5F

Q30974206-2AAAC2C5-0F30-43C6-BFD4-7FF143166532

Q30974206-32950F9D-48FD-4DCA-9792-D5147EA474B7

Q30974206-3F7A6FF6-2086-4AC0-9CC5-E62C87E0B799

Q30974206-58FB366B-C137-45DF-AE9A-C5DC66B5B867

Q30974206-5B0A8444-3F4D-450C-AB6D-C2D8854DFB6E

Q30974206-7DFC47A5-7CEE-4064-87FD-9C60C5EC6B5F

Q30974206-80F6B47C-7A91-4ADC-BB0F-FB7765C73E7F

Q30974206-9D3EECA5-A614-4108-BC74-CEEE6CAFE2C4

P304

Q30974206-2C57894E-64B2-4597-84E8-3CFFFEF076A4

P31

Q30974206-5D2DBE95-DB78-4395-AC82-CCBA930503AC

P356

Q30974206-8963284E-776B-494A-8025-561B7D5BF298

P407

Q30974206-F65FBFAB-0309-4B6D-A6ED-EB14EF8A5851

P433

Q30974206-2C53ED4E-BD4C-4FBD-9B9A-BABE0073D432

P478

Q30974206-9E26B6B1-D6F2-40D3-84A5-7B62D3D566C0

P50

Q30974206-9FEA2DE0-6234-43D8-97D0-3F0AE9DAACAB

Q30974206-D00BB19C-89C7-40B2-90AB-75D4A501D6EB

P577

Q30974206-58E63BE3-54B1-448A-A145-0E5D212464D4

P698

Q30974206-D9DA4E5A-FC29-4C0E-B898-C974EDD7A0FD

P356

SOPH.17.1.4.10287

P1433

Seminars in Ophthalmology

P1476

Treatment of acute demyelinating optic neuritis.

@en

P2860

Optic neuritis: A population-based study in Olrnsted County, Minnesota

Global visual field involvement in acute unilateral optic neuritis.

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Risk factors for developing multiple sclerosis after childhood optic neuritis.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings.

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis.

Comparison of central and peripheral visual field properties in the optic neuritis treatment trial.

Recovery of visual field function in the optic neuritis treatment trial.

P304

4-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1076/SOPH.17.1.4.10287

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15513449

http://www.w3.org/2001/XMLSchema#string